Xcout Intel
GENINCODE PLC
GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Subscribe to see GENINCODE PLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
GENINCODE PLC at a glance
GENINCODE PLC is a biotech company headquartered in Oxford, United Kingdom, founded in 2018. Xcout tracks 10 named people at GENINCODE PLC, including Bryan David Castellani (CFO & Director).
GENINCODE PLC leadership
- Bryan David CastellaniCFO & Director
- Chris DouganChief Communications Officer
- Jack Alexander DavisonChief Commercial Officer & Director
- Matt FleckensteinChief Product & Technology Officer
- Thomas RussellChief Legal Officer
- Tony MarlowChief Marketing Officer
4 more named people on record for GENINCODE PLC, with roles, board committees and tenure — see the full roster →
GENINCODE PLC competitors
A few of GENINCODE PLC's closest competitors — see the full list of competitors and alternatives →
Identifai Genetics is a clinical-stage biotechnology and health tech company developing advanced prenatal screening tests using AI, machine learning, and whole genome analysis. It is headquartered in Rosh Haayin, Israel.
PhiTech is a TechBio biotechnology company headquartered in Gebze, Kocaeli, Turkey. The firm leads a global shift from DNA-only diagnostics to AI-powered multi-omics, establishing new standards for precision medicine. Utilizing advanced bioinformatics and decision analysis, the company develops cutting-edge diagnostic tools.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Inocras Inc. is a bioinformatics-led biotechnology company headquartered in San Diego, California. The firm utilizes whole genome data and proprietary artificial intelligence analytics to deliver curated genomic care.
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Health in Code is a Spanish company that provides genetic and genomic diagnostic services, including sequencing, bioinformatics, and clinical interpretation. It serves hospitals, clinical laboratories, healthcare professionals, and patients, with a focus on hereditary and rare diseases such as inherited cardiovascular conditions.
Get GENINCODE PLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on GENINCODE PLC in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access